News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Sees Profit Hit from Health Reforms and Cuts


2/2/2011 6:49:20 AM

BASEL (Reuters) - Drugmaker Roche faces a double whammy in 2011 as demand for best-selling Avastin cancer drug slows and U.S. healthcare reforms combined with a drive by European governments to cut drugs bills eats into its profit.

Read at Reuters
Read at Bloomberg
Read at Financial Times
Read at AFP

comments powered by Disqus
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES